Vanguard Group Inc Nano Vibronix, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.25 - $9.02 $113 - $4,086	453 Added 0.07%	651,694 $162,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $10.32 $9 - $216	-21 Reduced -0.0%	651,241 $299,000
Q1 2022 May 13, 2022	BUY	$0.7 - $1.16 $159,217 - $263,846	227,454 Added 53.67%	651,262 $755,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.0 $100,889 - $201,778	100,889 Added 31.24%	423,808 $441,000
Q3 2021 Nov 12, 2021	BUY	$0.7 - $3.37 $9,800 - $47,180	14,000 Added 4.53%	322,919 $665,000
Q2 2021 Aug 13, 2021	BUY	$0.79 - $1.15 $244,046 - $355,256	308,919 New	308,919 $263,000

Ticker NAOV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,997,800
Market Cap $17.9M
Description
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.